Pfizer

When researching Pfizer, analysts typically begin with its Health Care sector positioning and Pharmaceuticals industry dynamics. Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

The company reports trailing twelve-month revenue of $14.45B and net income of $2.69B. Key metrics include a return on equity of 3.0%, a debt-to-equity ratio of 1.30.

FINOTAUR provides free research summaries, news aggregation, and fundamentals for PFE to support both active traders and long-term investors.